Sector Update: Healthcare; Valeant Partner Ackman Pursues Proxy Fight with Allergan
Healthcare stocks were generally lower in afternoon trading, with the S&P/TSX Healthcare index down 1.3%.
Valeant Pharmaceuticals (VRX.TO): -2.2%
Tekmira Pharmaceuticals (TKM.TO): -3.4%
Catamaran (CCT.TO): -0.3%
Oncolytics Biotech (ONC.TO): +1.5%
Cardiome Pharma (COM.TO): -1.1%
In corporate news, Valeant Pharmaceuticals' partner in its bid for Allergan, Bill Ackman, has decided to pursue a proxy fight with the NYSE-listed Botox-maker, several reports said. The Pershing Square CEO, who holds more than 9% stake in Allergan, reportedly called for a special meeting for shareholders to vote in favor of unseating six of the nine directors of Allergan board.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.